MIT Researchers Win Major Grants to Study Brain Circuits and Cancer Cell Death

What Happened

Two Massachusetts Institute of Technology researchers have received prestigious 2026 Searle Scholar awards, each providing $450,000 in flexible research funding over three years. Sven Dorkenwald, who studies brain circuit mapping, and Whitney Henry, who investigates new approaches to cancer cell death, were selected from a competitive pool for their high-risk, high-reward research potential. The Searle Scholars Program recognizes 15 exceptional early-career scientists annually in biomedical sciences and chemistry.

Key Details

The awards were announced on May 20, 2026, by the Kinship Foundation, which administers the program funded through the Searle Funds at The Chicago Community Trust. Key details include:

• Dorkenwald serves as assistant professor of brain and cognitive sciences and investigator at the McGovern Institute for Brain Research
• Henry holds the Robert A. Swanson Career Development Professor position and works at the Koch Institute for Integrative Cancer Research
• Each researcher receives $450,000 in unrestricted funding over three years
• Two MIT alumni, Irene Kaplow and Jared Mayers, also received 2026 Searle Scholar awards
• Recipients are chosen by a scientific advisory board for their creative research approaches

Why This Matters

These awards support fundamental research that could lead to breakthrough medical technologies and treatments. Dorkenwald’s work on brain circuit mapping advances our understanding of how neurons connect and communicate, which is essential for developing treatments for neurological disorders, brain injuries, and cognitive diseases. His computational tools help scientists create detailed maps of brain connectivity at the synapse level, potentially revealing how brain structure supports complex thinking and behavior.

Henry’s research into ferroptosis—a specific type of iron-dependent cell death—targets one of cancer’s most challenging problems: drug-resistant cells that cause tumor recurrence. By understanding how to manipulate this cellular death pathway, her work could lead to new therapies that eliminate the cancer cells most likely to survive current treatments and spread to other parts of the body.

Background and Context

The Searle Scholars Program has supported early-career biomedical researchers since 1980, with many recipients going on to make significant contributions to medicine and win major scientific honors. The program specifically targets scientists in their first few years of independent research, when flexible funding can be most impactful for establishing new research directions.

Dorkenwald’s research builds on recent advances in computational neuroscience and brain imaging technology. His previous work contributed to major brain mapping projects, including detailed reconstructions of fruit fly brains and sections of mammalian brains. This type of connectome research—mapping all neural connections in a brain or brain region—represents a rapidly advancing field that combines computer science, neuroscience, and advanced imaging techniques.

Henry’s focus on ferroptosis represents an emerging area in cancer research. Unlike other forms of cell death that cancer cells often learn to resist, ferroptosis involves iron accumulation and specific metabolic vulnerabilities that may be harder for cancer cells to overcome. This makes it a promising target for developing treatments against therapy-resistant cancers.

What Comes Next

Both researchers plan to use their Searle Scholar funding to launch ambitious new projects in their respective fields. Dorkenwald indicated the award will help establish his new laboratory and set long-term scientific directions for brain circuit research. Henry emphasized that the funding provides freedom to pursue bold, curiosity-driven questions and take creative risks in cancer research.

The three-year funding period allows these scientists to pursue longer-term research projects that might not receive support from traditional grant sources focused on shorter timelines or more established approaches. Readers should watch for future publications from both laboratories, as Searle Scholar research often leads to significant scientific breakthroughs within the funding period.

Source

This report is based on reporting from MIT News.

This article is for informational purposes only. Consult a licensed healthcare provider before purchasing or using any medical device.